Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of Piperine-Loaded Solid Self-Nanoemulsifying Drug Delivery System: Optimization, In-Vitro, Ex-Vivo, and In-Vivo Evaluation.
Zafar A, Imam SS, Alruwaili NK, Alsaidan OA, Elkomy MH, Ghoneim MM, Alshehri S, Ali AMA, Alharbi KS, Yasir M, Noorulla KM, Alzarea SI, Alanazi AS. Zafar A, et al. Among authors: alharbi ks. Nanomaterials (Basel). 2021 Oct 31;11(11):2920. doi: 10.3390/nano11112920. Nanomaterials (Basel). 2021. PMID: 34835684 Free PMC article.
Nanomedicine in treatment of breast cancer - A challenge to conventional therapy.
Afzal M, Ameeduzzafar, Alharbi KS, Alruwaili NK, Al-Abassi FA, Al-Malki AAL, Kazmi I, Kumar V, Kamal MA, Nadeem MS, Aslam M, Anwar F. Afzal M, et al. Among authors: alharbi ks. Semin Cancer Biol. 2021 Feb;69:279-292. doi: 10.1016/j.semcancer.2019.12.016. Epub 2019 Dec 20. Semin Cancer Biol. 2021. PMID: 31870940 Review.
Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights.
Al-Sanea MM, Elkamhawy A, Paik S, Lee K, El Kerdawy AM, Syed Nasir Abbas B, Joo Roh E, Eldehna WM, Elshemy HAH, Bakr RB, Ali Farahat I, Alzarea AI, Alzarea SI, Alharbi KS, Abdelgawad MA. Al-Sanea MM, et al. Among authors: alharbi ks. Bioorg Med Chem. 2020 Jul 1;28(13):115525. doi: 10.1016/j.bmc.2020.115525. Epub 2020 Apr 25. Bioorg Med Chem. 2020. PMID: 32371117
Nanotherapeutic systems for delivering cancer vaccines: recent advances.
Beg S, Alharbi KS, Alruwaili NK, Alotaibi NH, Almalki WH, Alenezi SK, Altowayan WM, Alshammari MS, Rahman M. Beg S, et al. Among authors: alharbi ks. Nanomedicine (Lond). 2020 Jun;15(15):1527-1537. doi: 10.2217/nnm-2020-0046. Epub 2020 May 15. Nanomedicine (Lond). 2020. PMID: 32410483
Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Ameeduzzafar, Alruwaili NK, Imam SS, Alotaibi NH, Alhakamy NA, Alharbi KS, Alshehri S, Afzal M, Alenezi SK, Bukhari SNA. Ameeduzzafar, et al. Among authors: alharbi ks. AAPS PharmSciTech. 2020 Jun 5;21(5):167. doi: 10.1208/s12249-020-01699-9. AAPS PharmSciTech. 2020. PMID: 32504176
Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment.
Alruwaili NK, Zafar A, Imam SS, Alharbi KS, Alotaibi NH, Alshehri S, Alhakamy NA, Alzarea AI, Afzal M, Elmowafy M. Alruwaili NK, et al. Among authors: alharbi ks. Int J Nanomedicine. 2020 Jun 30;15:4717-4737. doi: 10.2147/IJN.S254763. eCollection 2020. Int J Nanomedicine. 2020. Retraction in: Int J Nanomedicine. 2023 Mar 21;18:1363-1364. doi: 10.2147/IJN.S413304 PMID: 32636627 Free PMC article. Retracted.
113 results